Ashish Sagrolikar joined Pulmocide in 2023 as the Chief Commercial Officer. Prior to this role, Ashish provided global leadership for commercial and operations functions at leading healthcare companies, such as Baxter Healthcare, GlaxoSmithKline, and Zogenix Inc. At Zogenix, he led the transformation of the company from a development-focused organization to a fully integrated, commercial stage company. Ashish built the capabilities and talent that streamlined the processes bringing product efficiently from development stage to the market, enabling successful launches in the US and Europe. Under his leadership, Zogenix delivered successful top line results, beating expectations for six consecutive quarters before it was acquired by UCB SA for $1.9 billion. He is also the treasurer and member of the Executive Committee at Triangle Angel Partners and serves on the board of Orbital Rx, a health tech company as board observer.
Ashish is a pharmacist by training and earned his MBA from the Institute of Management Development (IMD) in Lausanne, Switzerland.